Barriers to cardiovascular risk prevention and management in Germany – an analysis of the EURIKA study

Roland E Schmieder 1, Matthias Goebel2, Peter Bramlage31Nephrology and Hypertension, University Hospital Erlangen, Germany; 2AstraZeneca GmbH, Medical Department, Wedel, Germany; 3Institut für Pharmakologie und präventive Medizin, Mahlow, GermanyBackground and purpose: Desp...

Descrizione completa

Dettagli Bibliografici
Autori principali: Schmieder RE, Goebel M, Bramlage P
Natura: Articolo
Lingua:English
Pubblicazione: Dove Medical Press 2012-03-01
Serie:Vascular Health and Risk Management
Accesso online:http://www.dovepress.com/barriers-to-cardiovascular-risk-prevention-and-management-in-germany-n-a9495